Retinal Imaging Study of Children That Might be at Risk of Having Retinal Hemorrhages (RISC)

February 7, 2023 updated by: Kerstin Hellgren, Region Stockholm

This is a clinical trial in which we will learn about the retinal findings in three clinical groups of children, who might be at risk of having retinal hemorrhages (RH). The aim of the study is to explore the occurrence of moderate to severe retinal hemorrhages in critically ill children, children with intracranial hemorrhages, hydrocephalus or signs of elevated intracranial pressure and in children with benign enlargement of subarachnoid spaces (BESS).

  1. Are RHs associated with BESS?
  2. What is the prevalence, distribution and extent of RHs in critically ill children?
  3. What is the prevalence, distribution and extent of RHs in children with traumatic brain injury?
  4. Does the prevalence, distribution and extent of RHs differ in children with witnessed traumatic brain injury from children with traumatic brain injury of unknown origin?
  5. To what extent do the causes of RHs affect visual acuity, initially and during recovery? A retinal ophthalmoscopy through dilated pupils will be conducted and a fundus photograph will be taken by a handheld, non-touch camera.

Study Overview

Detailed Description

The prospective study will take place at university hospitals in three Swedish regions, Stockholm, Skåne and Västra Götaland. The data collection from the three regions will proceed in parallel over a three-year period. An estimated number of children will be 400-500 per year. The study children will be consecutively referred to the pediatric ophthalmology units, where the ophthalmological examinations will take place. Bedside examinations will be performed when indicated at the pediatric intensive care units. Retinal fundus examination will be performed according to clinical standards following administration of pupil dilating eye drops in each eye. Visual function will be evaluated if ophthalmic abnormalities are detected.

Prospective observational study Group 1: All infants ≤ 18 months of age, who undergo neuroradiological examinations of the brain on the indication increased head circumference.

Group 2: All critically ill children < 15 years of age, cared for at the hospitals, with neurological symptoms, that require neuroradiological examination of the brain.

Group 3: All children ≤ 2 years of age, who undergo emergency neuroradiological examinations of the head at the hospitals.

Study Type

Observational

Enrollment (Anticipated)

1500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Stockholm, Sweden, 17164
        • Recruiting
        • Kerstin Margareta Hellgren
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 weeks to 14 years (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Residents in the Stockholm region, the Skåne region and the Västra Götaland region

Description

Inclusion Criteria:

  • Infants ≤ 18 months of age, who undergo neuroradiological examinations of the brain on the indication increased head circumference
  • Children < 15 years of age, cared for at the ICU, with neurological symptoms, that require neuroradiological examination of the brain
  • Children < 5 years of age, who undergo emergency neuroradiological examinations of the head at the hospitals

Exclusion Criteria

- Infants with intraventricular hemorrhages due to prematurity, in the absence of increased head circumference

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Accelerating head growth in infancy
Infants <=18 months of age referred to head ultrasound because of accelerating head growth
ophthalmoscopy and fundus photography through dilated pupills
Children at ICU with neurological symptoms that require brain MRI or CT
Children < 15 years of age who are cared for at ICU becaus of neurological symptoms that require brain MRI or CT scans
ophthalmoscopy and fundus photography through dilated pupills
Children entering the emergency department with the need of acute brain CT
Children < 2 years of age that enter the emergency department because of brainthreatening conditions that require acute brain CT scans
ophthalmoscopy and fundus photography through dilated pupills

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients with retinal hemorrhages
Time Frame: 20 minutes
Ophthalmoloscopy findings registered in protocol and fundus photographs
20 minutes
Number and distribution of retinal hemorrhages in eyes
Time Frame: 20 minutes
Ophthalmoloscopy findings registered in protocol and fundus photographs
20 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Visual function
Time Frame: 10 minutes
Following and fixating LH face
10 minutes
Eye movements
Time Frame: 10 minutes
Following and fixating LH face
10 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

February 8, 2023

Primary Completion (ANTICIPATED)

February 8, 2026

Study Completion (ANTICIPATED)

February 8, 2026

Study Registration Dates

First Submitted

September 29, 2022

First Submitted That Met QC Criteria

October 7, 2022

First Posted (ACTUAL)

October 12, 2022

Study Record Updates

Last Update Posted (ESTIMATE)

February 9, 2023

Last Update Submitted That Met QC Criteria

February 7, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Dnr 2022-00506-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Retinal Hemorrhage, Bilateral

Clinical Trials on ophthalmoscopy and fundus photography through dilated pupills

3
Subscribe